PAR 0.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-61

  1. 749 Posts.
    lightbulb Created with Sketch. 137
    What is your point Bedger?

    The management's forecasts are woefully inaccurate and these new forecasts can't be believed.
    Did you look at what was indicated only 2 months ago cf. what we just received today? $10mill+ difference in cash outflow.

    So even with using the upper limit of their forecast cash outflow, which based on the previous 2 quarterlies is likely to be wildly underestimated, they likely will have $0 cash by the end of Sept 2024. Oppies don't need to be converted until November 2024, so they must get a MPS deal, but how much is that likely to be? I'd think $10mill max and IF the Phase III stage 2 restart does occur, that $10mill will be burnt in 6-8 weeks, so cash runs out by November 2024 (assuming they run the bank balance to $0).

    Where's the next funding coming from Bedger? How much to you believe their cash outflow forecasts, especially based on their abject forecasts for the past 6 months.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $85.7M
Open High Low Value Volume
25.0¢ 25.5¢ 24.5¢ $112.3K 450.3K

Buyers (Bids)

No. Vol. Price($)
5 322039 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 46325 3
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.